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In Brief
Notch is essential for metazoan
development and is mutated in human
cancers. Broadus et al. identify a paralog-
specific degron (N1-Box) that promotes
degradation of the Notch1 intracellular
domain, thereby limiting Notch1 pathway
activity. Cancer mutations within the N1-
Box exhibit enhanced Notch1 signaling in
zebrafish, highlighting the importance of
N1-Box in proper Notch1 signaling.
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Upon Notch pathway activation, the receptor is
cleaved to release the Notch intracellular domain
(NICD), which translocates to the nucleus to activate
gene transcription. Using Xenopus egg extracts, we
have identified a Notch1-specific destruction signal
(N1-Box). We show that mutations in the N1-Box
inhibit NICD1 degradation and that the N1-Box is
transferable for the promotion of degradation of het-
erologous proteins in Xenopus egg extracts and in
cultured human cells. Mutation of the N1-Box en-
hances Notch1 activity in cultured human cells and
zebrafish embryos. Human cancer mutations within
the N1-Box enhance Notch1 signaling in transgenic
zebrafish, highlighting the physiological relevance
of this destruction signal. We find that binding of
the Notch nuclear factor, CSL, to the N1-Box blocks
NICD1 turnover. Our studies reveal a mechanism
by which degradation of NICD1 is regulated by the
N1-Box to minimize stochastic flux and to establish
a threshold for Notch1 pathway activation.INTRODUCTION
The Notch pathway is a highly conserved, metazoan signaling
pathway critical for organismal development (Kopan and Ilagan,
2009). The Notch pathway communicates transcriptional de-
cisions between adjacent cells through direct interaction of a
Delta/Serrate/Lag-2 (DSL) type 1 transmembrane ligand on the
signaling cell and a Notch type 1 transmembrane receptor on a
receiving cell. This interaction promotes a series of proteolytic1920 Cell Reports 15, 1920–1929, May 31, 2016 ª 2016 The Author(s
This is an open access article under the CC BY license (http://creativeevents resulting in liberation of the Notch intracellular domain
(NICD) from its membrane tether. Liberated NICD enters the nu-
cleus, where it forms a complex with CSL (CBF1/RBPjk/Su(H)/
Lag-1), MAML (Mastermind-like), and CoA (coactivators) (Kovall
and Blacklow, 2010). Formation of this complex drives transcrip-
tion of Notch target genes. In the prevailing model, transcrip-
tional termination is mediated, in part, by the E3 ubiquitin ligase
complex, SCFFbxw7, which promotes ubiquitin-mediated degra-
dation of NICD in a PEST domain-dependent manner (Moretti
and Brou, 2013). Herein, we identify a hNICD1-specific degron
within the N-terminal region distinct from its C-terminal PEST
domain.
RESULTS
NICD1 Is Degraded in Xenopus Extract
To recapitulate cytoplasmic NICD turnover, we used the Xeno-
pus extract system previously shown to support b-catenin
degradation via Wnt pathway components (Chen et al., 2014).
In our Xenopus extract system, no ongoing transcription or
translation confounds our results. We found that radiolabeled
in-vitro-translated (IVT) hNICD1 degraded robustly when added
to Xenopus extract (Figure 1A). Addition of MG132, a pro-
teasome inhibitor, inhibited degradation of both radiolabeled
hNICD1 and b-catenin (Figure 1A). Excess recombinant b-cate-
nin inhibited turnover of radiolabeled b-catenin but had no effect
on hNICD1 turnover (Figure 1B). Thus, hNICD1 degradation in
Xenopus extract occurs in a proteasome-dependent manner
distinct from that of b-catenin.
NICD Degradation within Xenopus Extract Is Restricted
to the NICD1 Paralog
In contrast to hNICD1, we found that its paralogs (hNICD2,
hNICD3, and hNICD4) were stable throughout the time course).
commons.org/licenses/by/4.0/).
Figure 1. hNICD1 Is Degraded in Xenopus Egg Extract
(A) In-vitro-translated (IVT) [35S]hNICD1 and [35S]b-catenin were incubated in extract with DMSO (–) or MG132 (+). Samples were analyzed by SDS-PAGE/
autoradiography.
(B) Same as for (A), except extract was supplemented with GST or GST-b-catenin.
(C) Schematic of human NICD paralogs. RAM, RBP-Jk-associated module domain; ANK, ankyrin repeats domain; TAD, transcriptional activation domain; PEST
is proline-, glutamic-acid-, serine-, and threonine-rich region.
(D) Radiolabeled hNICD paralogs were incubated in extract, and samples were removed at the indicated times for SDS-PAGE/autoradiography.
(E) Graph of mean ± SD densitometry measurements for autoradiography experiments.
(F) Degradation of IVT hNICD luciferase fusions incubated in extract parallels degradation of radiolabeled, untagged versions. Graph is mean luciferase signal for
two independent experiments (performed in triplicate) and normalized to initial time point (100%).
See also Figure S1.of our experiment (Figure 1C–1E). To quantify the degradation of
NICD proteins in Xenopus extract, hNICD paralogs were fused at
their C-terminal ends to firefly luciferase (Chen et al., 2014).
Although a high background signal is caused by use of internal
translational start sites (Chen et al., 2014), the hNICD1 luciferase
fusion had a similar half-life as radiolabeled hNICD1 (Figures 1F
and S1A). hNICD2, 3, and 4 luciferase fusions were stable,
similar to their radiolabeled non-fusion proteins (Figure 1F).
This differential degradation was conserved for mouse NICD1
and NICD4 (Figure S1B). We found that the single Drosophila
NICD ortholog was stable in Xenopus extract (Figure S1B).
The N-terminal End of hNICD1 Contains a Degron
Required for Degradation in Xenopus Extract
Next, we assessed the turnover rates of NICD proteins in Xeno-
pus extract versus cultured human cells. We found that NICD-
MYC fusions had turnover rates essentially identical to those of
their non-tagged versions in extract (Figure S1C). In contrast,
all NICD paralogs degraded at similar rates in cultured human
cells (Figure S1D), consistent with previous reports (Fryer et al.,
2004; Malyukova et al., 2007; Mo et al., 2007; Palermo et al.,
2012; Tsunematsu et al., 2004).
The degradation differences between Xenopus extract and
cultured cells suggest that an uncharacterized degron exists
in mammalian NICD1 mechanistically uncoupled in Xenopus
extract. To identify the NICD1-specific degron, we generated
chimeric proteins in which N-terminal or C-terminal portions of
hNICD1 were swapped with corresponding portions of otherhNICD paralogs (Figures S1E–S1L). These results identified
the N terminus of hNICD1 as necessary for its instability within
Xenopus extract. To narrow the N-terminal portion of hNICD1
responsible for degradation, smaller corresponding swaps of
hNICD2 were made with hNICD1 (Figure 2A). We found that
the N-terminal 35-amino-acid fragment of hNICD1 was sufficient
to confer degradation of hNICD2 (Figures 2B and S1E–S1L).
These results show that the amino terminus of hNICD1 contains
a Notch1-specific degron (N1-Box) necessary and sufficient to
degrade hNICD1 in Xenopus extract.
The N-terminal ends of the human NICD paralogs (Figure 2C)
contain non-conserved residueswithin the first 35 amino acids of
hNICD1 (residues 1754–1788 of Notch1) that may mediate its
degradation. To test this possibility, we mutated these residues
to the corresponding hNICD2 residues. In contrast to wild-type
hNICD1, the L1755D, S1757M, and Q1763K single mutants
and triple-mutant hNICD1LSQ were stable in extract (Figures
2D, 2E, and S2A). hNICD1NTD10, which lacks the N-terminal ten
residues of hNICD1, was also stable in extract, confirming the
importance of this region in mediating hNICD1 stability (Fig-
ure S2A). All five mutant proteins tested could activate a
HES1-luciferase reporter, indicating that they were not grossly
misfolded (Figures 2F and 2H). Furthermore, the stabilized mu-
tants demonstrated enhanced reporter activity. The Q1766S
mutant demonstrated a slight increased stability in Xenopus
extract, although Hes1-Luc activation was similar to wild-type.
This may reflect subtle differences between Xenopus extracts
and mammalian cultured cells.Cell Reports 15, 1920–1929, May 31, 2016 1921
To assess whether the N-terminal region of hNICD1 could pro-
mote protein turnover in an autonomous fashion, we fused the
N-terminal 50 residues of hNICD1 to luciferase. In contrast to
luciferase, hNICD1(1-50)-Luc degraded in extract (Figure S2B).
The analogous N1-Box mutants (L1755, S1757, and Q1763) in
the hNICD1(1-50)-Luc fusion were stable in Xenopus extract
(Figure S2B). Next, we altered the first ten residues of NICD2
to those corresponding to NICD1. We found that the chimera,
NICD1/2NT10, did not have an increased rate of degradation
when compared to wild-type NICD2 (Figure S2C). Enhanced
degradation of NICD2, however, was observed on addition of
the N-terminal 35 amino acids of NICD1 (Figure S2C). Thus,
the N-terminal 35 amino acids of NICD1 constitute the minimal
transferable element capable of promoting degradation of the
Notch intracellular domain in Xenopus extract.
Next, we tested whether N1-Box-regulated degradation of
hNICD1 functioned in cultured cells. The N1-Box mutants
hNICD1NTD10 and hNICD1LSQ were expressed in HEK293 cells,
and protein levels assessed by immunoblotting (Figure 2G).
Both mutant proteins had higher steady-state levels than did
wild-type hNICD1 (Figures 2G and S3A). Consistent with their
increased stability, both hNICD1NTD10 and hNICD1LSQ had
enhanced transcriptional activity (Figure 2H). To test autonomous
function of the hNICD1 N1-Box in human cells, we fused the N1-
Box to GFP and monitoring turnover by live-cell imaging. In
contrast toGFP, hNICD1(1-50)-GFPshowed lossof fluorescence
at a rate similar to that of full-length hNICD1-GFP (Figures S2D
and S2E). A N1-Box double mutant (hNICD1(1-50)LS-GFP) and
GFP fusions of the first 50 residues of hNICD2 and 3 did not
exhibit substantial turnover (Figure S2E). These results suggest
the degradation machinery for the N1-Box of hNICD1 is evolu-
tionarily conserved. We observed turnover of the N1-Box GFP
fusion in both the nucleus and cytoplasm, suggesting that N1-
Box-mediated degradation could occur in both compartments.
The N1-Box Controls hNICD1 Stability and Activity
In Vivo
To ensure that the N1-Box functioned in the complete Notch1 re-
ceptor, and to further demonstrate evolutionary conservation,
we generated the analogous N1-Boxmutant in full-length mouse
Notch1 (mNotch1LSQ). Consistent with our hNICD1 studies,
mNotch1LSQ exhibited elevated Notch transcriptional activity
compared to wild-type mNotch1 (Figure S3B).
To demonstrate that the N1-Box regulates Notch1 function
in vivo, we assessed its effects on somite formation in zebrafish
embryos. Notch1 plays a role in vertebrate somitogenesis (Har-
ima and Kageyama, 2013; Lewis et al., 2009), and misregulation
of Notch signaling during development results in disruption of the
symmetric, bilateral somites (Figure 3A). This biological readout
was dose sensitive (Figure 3B). Consistent with a role for N1-Box
in vivo, injecting mRNA of the N1-Box mutant, mNotch1LSQ,
caused defective somite formation in nearly double that of
mNotch1 mRNA injected emybros (Figure 3B). It is possible
that the enhanced activity of the NICD1 N1-Box mutant is due
to its more efficient processing. A mutation in the HD domain
of human Notch1 (L1601P) resulted in a constitutively activated
‘‘leaky’’ Notch1 receptor due to its constitutive cleavage from
the plasma membrane (Chiang et al., 2006; Thompson et al.,1922 Cell Reports 15, 1920–1929, May 31, 20162007; Weng et al., 2004). When combined, the mNotch1L1601P;
LSQ mutant had an additive defect in somitogenesis (Figure 3B).
These results suggest that the greater activity of the Notch1LSQ is
due to increased stability and not more efficient processing.
Inhibition of neural differentiation is a major role of Notch
signaling during development. Using the transgenic zebrafish
line, Tg(NGN1:GFP), which expresses GFP controlled by the
neurogenin1 (ngn1) promoter (marks primary neurons) (Blader
et al., 2003), we found that injection of mNotch1 mRNA de-
creases the normal ngn1 expression along the rostral-caudal
axis (particularly in the hindbrain) (Figures 3C and S3C).
mNotch1LSQ led to a severe decrease in expression of GFP,
consistent with its more potent activity. In contrast, injection of
mNotch1 mRNA into Tg(Her4:dRFP), a zebrafish line that ex-
presses RFP under control of the promoter for her4, a Notch
target gene (Yeo et al., 2007), enhanced RFP expression
throughout the central nervous system (Figures 3C and S3C).
The expression of RFP was further enhanced (extended
caudally) when mNotch1LSQ mRNA was injected.
Mutations within the N1-Box Found in Human Tumors
Inhibit hNICD1 Degradation
Using theNIHCatalog of SomaticMutations in Cancer database,
we identified two mutations (R1758S and S1776C) in patient tu-
mors located within the first N-terminal 35 residues of hNICD1
(Figure 3D). We found that both mutants exhibit elevated Notch
transcriptional activity and steady-state protein levels (Figures
3E and 3F). These mutants also have enhanced activity in vivo
as indicated by significantly greater somitogenesis defects on in-
jection of their mRNAs into zebrafish embryos (Figure 3G).
To demonstrate physiologically relevance, we generated
transgenic zebrafish encoding the humanmutations in the corre-
sponding positions of endogenous zebrafish Notch1 by
CRISPR/Cas9-mediated knockin. For all embryos, we per-
formed PCR followed by sequencing to confirm the absence or
presence of mutations. We found that all embryos harboring
R1758S or S1776C exhibited disrupted somitogenesis (Fig-
ure 3H). In contrast, embryos with the wild-type phenotype did
not harbor mutant sequences. As control, transgenic animals
harboring silent mutations within the N1-Box were generated.
We found that none of silent N1-Box mutants exhibited defects
in somitogenesis. Transgenic R1758S and S1776C animals
demonstrated decreased GFP expression from the ngn1 pro-
moter and enhanced RFP expression from the her4 promoter
(Figures 3I–3L), consistent with enhanced Notch1 signaling.
These changes are not due to gross disruption in embryonic
structures (Figures S3D and S3E). No changes in GFP or RFP
expression were observed for the control silent mutant embryos.
These studies provide strong evidence for an in vivo role of the
N1-Box in regulating Notch1 signaling.
The N1-Box Facilitates hNICD1 Degradation
Independent of Other cis Stability Elements
Two cis elements have been identified within the NICD PEST
domain that facilitate turnover: the LTPSPE sequence recog-
nized by the SCFFbxw7 complex (Fryer et al., 2002, 2004; O’Neil
et al., 2007; Thompson et al., 2007) and the WSSSSP sequence
(Chiang et al., 2006).We tested the relative contributions of these
Figure 2. Mutation of N1-Box Inhibits hNICD1 Degradation in Xenopus Egg Extract and Elevates Steady-State Levels and Transcriptional
Activity in Cultured Human Cells
(A) Schematic of hNICD1 and hNICD2 chimeras. Parentheses indicate the number of N-terminal residues of hNICD1 in each chimera.
(B) Radiolabeled hNICD1/2 chimeras containing at least the N-terminal 35 residues of hNICD1 degraded robustly in Xenopus egg extract.
(C) Alignment of N-terminal regions of human NICD paralogs.
(legend continued on next page)
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two elements and the N1-Box to NICD1 stability. Consistent
with previous studies, mutation of LTPSPE (S2514A/S2517A;
hNICD1S2A), WSSSSP (hNICD1W4AP), both LTPSPE and
WSSSSP (hNICD1S2A/W4AP), or truncation of the PEST region
(hNICD1S2493D) resulted in increased protein levels in cultured
cells (Figure 2G) (Chiang et al., 2006; Fryer et al., 2004; O’Neil
et al., 2007; Thompson et al., 2007; Weng et al., 2004). Increased
steady-state levels of hNICD1S2A and hNICD1W4AP were also
observed in combination with NTD10. Interestingly, combining
hNICD1NTD10 with W4AP and/or S2493D, but not with S2A,
enhanced protein levels. All stabilizing mutants demonstrated
enhanced HES1 reporter activation, and protein levels of each
hNICD1 mutant roughly correlated with the degree of activation
of Notch transcription (Figure 2H).We observed a similar effect in
zebrafish embyros in which injected Notch1LSQ/S2647D (S2647D
is the mouse PEST deletion) was more potent in disrupting somi-
togenesis (Figure 3B). These results suggest that WSSSSP and
the N1-Box act independent of each other. The absence of
further activation by hNICD1NTD10 or hNICD1W4AP on mutation
of the Fbxw7 binding site may indicate that stabilization by
NTD10 or WSSSSP fully saturates the SCFFbxw7 complex, which
may be limiting.
The N1-Box Is Not Regulated by Fbxw7 or Itch
In addition to known cis factors, we also assessed whether two
known NICD E3 ubiquitin ligases contributed to N1-Box-medi-
ated degradation. We overexpressed Fbxw7 and a dominant-
negative form (Fbxw7DN) (Skaar et al., 2013; Wu et al., 2001).
As previously reported, overexpression of Fbxw7 decreased,
and Fbxw7DN increased, steady-state levels of hNICD1 (Fig-
ure S4A) (Gupta-Rossi et al., 2001; Wu et al., 2001). In contrast,
overexpressing Fbxw7 or Fbxw7DN did not affect levels of the
Fbxw7 binding site mutant, hNICD1S2A (Figure S4A). The effects
of overexpressing Fbxw7 and Fbxw7DN on wild-type hNICD1
were similarly observed for hNICD1W4AP (Figure S4A), consistent
with our results and a previous study suggesting that WSSSSP
acts independent of the SCFFbxw7 complex (Chiang et al.,
2006). A similar effect was observed for NICD1NTD10, indicating
that the N1-Box mediates degradation of NICD1 independent
of the SCFFbxw7 complex.
All NICD paralogs contain a C-terminal PEST domain recog-
nized by the SCFFbxw7 ubiquitin ligase (Gupta-Rossi et al.,
2001; Moretti and Brou, 2013; Oberg et al., 2001; Wu et al.,
2001). The Fbxw7 isoform shown to ubiquitinate NICD proteins
is localized to the nucleus (O’Neil et al., 2007). In support of(D) Mutation of hNICD1 non-conserved residues at position L1755, S1757, or Q
region. Intervening lanes were removed. The lower bands observed in (B) and
N-terminal fragment) resistant to degradation (Chen et al., 2014).
(E) Mean ± SD quantification of densitometry for experiments represented in (D).
(F) N-terminal mutants of hNICD1 are transcriptionally active as assessed by HE
measured after 24 hr. Graph represents ± SD of luciferase signal normalized t
triplicate). ***p < 0.0001, **p < 0.05 relative to hNCID1. ns, not significant.
(G) N1-Box mutants (hNICDNTD10 and hNICDLSQ), Fbxw7 binding mutant (hNIC
HEK293 cells, and immunoblotting of lysates was performed. Tubulin was used
(H) Stabilizing hNICD1 N1-Box mutants, Fbxw7, and WSSSP exhibit higher trans
activity in HEK293 cells. Luciferase activity was measured after 24 hr. Graphs sho
two independent experiments (performed in triplicate). **p < 0.002 relative to hN
See also Figures S2, S3, and S4.
1924 Cell Reports 15, 1920–1929, May 31, 2016this, we could not detect Fbxw7 by immunoblotting Xenopus
extract, which does not contain nuclei (Figure S4B). In addition,
two Fbxw7 binding mutants hNICD1S3A and hNICDS2493D
degraded at rates indistinguishable from that of wild-type
hNICD1 (Figures S4C–S4F). Thus, the incapacity of extract to
degrade NICD2-4 is likely due to the absence of Fbxw7, and
NICD1 degradation in Xenopus extract does not require its
PEST domain or Fbxw7.
The E3 ligase, Itch, promotes PEST domain-independent
NICD1 degradation (Qiu et al., 2000). As previously shown, over-
expression of Itch decreased, whereas overexpression of a
dominant-negative form, ItchC380A, increased, hNICD1 steady-
state levels in HEK293 cells (Figure S4G). We obtained similar re-
sults for all of our mutants, indicating that Itch does not mediate
NICD1 degradation through the N1-Box.
hNICD1 Turnover Is Inhibited by CSL
Based on sequence overlap between the N1-Box and RAM
domain (the major cis factor involved in CSL binding (Nam
et al., 2003; Tamura et al., 1995) (Figure 4A), we tested whether
binding of CSL to hNICD1 could influence hNICD1 stability.
Given the cytoplasmic nature of Xenopus egg extract (lacks
nuclei), it likely contains low levels of CSL. Incubation of recom-
binant CSL with Xenopus extract inhibited hNICD1 degradation
in a dose-dependent manner (Figures 4B and 4C). Inhibition of
hNICD1 degradation by CSL requires direct binding because
degradation of hNICD11771-74A, which cannot bind CSL (Chu
and Bresnick, 2004; Vasquez-Del Carpio et al., 2011), is not
inhibited by recombinant CSL (Figures 4B and 4C). In cultured
human cells, where CSL is present, we predicted that
hNICD11771-74A would be less stable than wild-type hNICD1. In
support of this idea, we observed lower steady-state levels of
hNICD11771-74A than for wild-type hNICD1 when expressed in
HEK293 cells (Figures 4D and 4E).
Degradation of NICD via the SCFFbxw7/PEST domain depends
on assembly of a CSL transcriptional complex (Fryer et al., 2002,
2004). We predicted that hNICD11771-74A instability is primarily
mediated by the N1-Box. Thus, an N1-Box/CSL-binding double
mutant should be more stable than the N1-Box mutant, and a
hNICD1 PEST/CSL binding double mutant should be less stable
than a PEST domain mutant due to enhanced N1-Box-medi-
ated degradation. Consistent with this idea, we found that
hNICD1NTD10/1771-74A steady-state levels are statistically higher
than those of hNICD1NTD10 and that hNICD11771-74A / S2493D
steady-state levels are lower than those of hNICD1S2493D1763 inhibits degradation in extract. D, amino acid deletion; KRR, lysine-rich
(D) represent an internal translational initiation product (thus are missing an
Data are from three independent experiments. **p < 0.05; ns, not significant.
S1-luciferase Notch reporter activity in HEK293 cells. Luciferase activity was
o Renilla luciferase of at least three independent experiments (performed in
D1S2A), WSSSSP mutant (hNICD1W4AP), or combinations were expressed in
as a control.
criptional activity than does hNICD1 as assessed by HES1-luciferase reporter
w mean ± SD of the luciferase signal normalized to Renilla luciferase of at least
ICD1.
(legend on next page)
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(Figures 4D and 4E). These results suggest that CSL binding
to NICD1 inhibits its turnover by blocking N1-Box-mediated
degradation.
DISCUSSION
Evidence for an in vivo role of the N1-Box comes from a previous
report showing that a chimeric receptor containing the Notch2
extracellular domain and Notch1 intracellular domain (Notch21)
is 2-fold more active than is a wild-type Notch1 when expressed
at similar levels in mice (Liu et al., 2013). Interestingly, the
Notch21 chimeric fusion deleted the N1-Box of NICD1. Our
data suggest that increased activity of this chimera is due to
increased stability of its intracellular domain. We propose a
model (Figure 4F) in which liberated NICD1 (on cleavage from
the Notch1 receptor) has two possible fates: (1) rapid degrada-
tion and inactivation via its N1-Box or (2) binding to CSL and
Notch transcriptional complex components to drive Notch target
gene transcription. Termination of Notch1 signaling occurs on
ubiquitin-mediated degradation by the SCFFbxw7/proteasome.
It is not as clear why a cell needs to regulate cytoplasmic
NICD1 degradation. One possibility is that this system dampens
stochastic flux in the system, thereby minimizing noise: a
threshold level of Notch receptor activation must occur for acti-
vation of transcription. Indeed, recent models of juxtacrine
signaling indicate that such systems are inherently noisy (Yaron
et al., 2014). This may explain why Drosophila NICD does not
have an N1-Box, as stochastic flux in Notch signaling plays an
important role during neuroblast differentiation via lateral inhibi-
tion (Artavanis-Tsakonas et al., 1999). Conversely, once the tran-Figure 3. Notch1 N1-Box Mutants Found in Human Cancers Have Incr
(A) The N1-Box Notch1 mutant exhibits enhanced capacity to disrupt somitogen
bryos, uninjected and injected (100 pg of mNotch1 mRNA). Inset is higher magn
(B) Quantification of zebrafish embryos (10–13 somite stage) with defective somite
clutch. n = 78–200 embryos per injection. **p < 0.05 relative to 25 pg Notch1 mR
except for comparison to Notch1 100 pg injection (not significant).
(C) (Top) Injection into the zebrafish line, Tg[NGN1:GFP], that expresses GFP in pri
83magnification. Embryos with reduced GFP expression: uninjected = 0/44, mN
into the zebrafish line, Tg[Her4:dRFP], that expresses RFP under the control of
magnification. Data are from at least three clutches collected from three differen
mNotch1 = 60/68, and mNotch1LSQ = 45/53. Injection of 25 pg. Hpf is14 hr post
(D) Table of somatic mutations found within residues 1754–1788 of hNotch1 (res
(E) Human cancer mutants in the N1-Box expressed in HEK293 cells show elevat
signal normalized to Renilla luciferase of at least three independent experiments
(F) hNotch1 R1758S and S1776Cmutants expressed in cultured cells have elevat
were removed.
(G) Quantification of 10–13 somite stage zebrafish embryos with defective somite
collected from three different breeding pairs. n = 30–320 embryos per injection.
(H) Zebrafish embryos were injected with Cas9 nuclease mRNA, short guide R
Notch1 silent mutation (control). Transgenics expressing the R1758S or S1776C m
somitogenesis defects are observed in transgenics harboring silent mutations o
somite stage) with defective somites. Number of embryos: uninjected = 210, con
(I–L) R1758S and S1776C transgenic mutants exhibit decreased GFP (I) and in
respectively, when compared to uninjected and Notch1 silent mutant embryos. F
Embryos with reduced GFP expression: uninjected = 0/75, control = 0/44, R1758
are shown at 53 magnification. Embryos with enhanced RFP expression: uninjec
relative to control injected embryos. Scale bar, 0.3 mm. For (J) and (L), graphs sh
expression (L). Sequencing confirms the presence of the mutations for all affected
Embryos are 14 hr post-fertilization. FB, forebrain; MB, midbrain; HB, hindbrain;
See also Figure S3.
1926 Cell Reports 15, 1920–1929, May 31, 2016scriptional complex is fully saturated (i.e., all CSL is occupied by
NICD1), unbound NICD1 could be degraded to limit the activa-
tion window. This model is consistent with the digital response
model proposed for Notch1 pathway activation (Ilagan et al.,
2011).
We favor a model in which N1-Box mutants stabilize NICD1
protein by directly disrupting the interaction of NICD1 with an
as yet unknown E3 ligase. Because the N1-Box and the RAMdo-
mains overlap, however, it is possible that certain cancer muta-
tions may enhance NICD1-CSL interaction and indirectly block
the action of the E3 ligase. Activating mutations in Notch have
been found in a large percentage of T-ALL cases. To date, we
have not found N1-Box mutations in T-ALL. It is possible that
T cells have other mechanisms to control cytoplasmic levels of
NICD1. Alternatively, turnover by other E3 ligases (e.g., Fbxw7
and/or Itch) may be the predominant mechanism by which cyto-
plasmic NICD1 levels are regulated.EXPERIMENTAL PROCEDURES
Animals
All Xenopus laevis and zebrafish studies were approved by the Vanderbilt
University Institutional Animal Care and Use Committee and were performed
in accordance with institutional and federal guidelines. See Supplemental
Information for more details.
Cell Culture
HEK293 cells were maintained in DMEM (Corning) supplemented with 1%
L-glutamine, 10% (v/v) fetal bovine serum, 100 mg/ml streptomycin, and
100 U/ml penicillin at 37C with 5% CO2. Transient transfections were per-
formed using Fugene HD (Promega) in accordance with the manufacturer’seased Activity in Cultured Human Cell and Zebrafish Embryos
esis in embryos. Representative images of 10–13 somite stage zebrafish em-
ification.
s. Data are from three clutches collected from three different breeding pairs per
NA injection. ***p < 0.005 relative to 25 pg hNICD1LSQ; S2467D mRNA injection,
mary neurons under control of the ngn1 promoter. Coronal views of embryos at
otch1 = 24/32, and mNotch1LSQ = 17/40. Injection of 25 pg. (Bottom) Injection
the her4 Notch target gene promoter. Sagittal view of embryos (14 hpf) at 53
t breeding pairs. Embryos with increased RFP expression: uninjected = 0/75,
-fertilization. Scale bar, 0.3 mm.
idues 1–35 of hNICD1) from the COSMIC database.
ed HES1-luciferase reporter activity. Graph shows mean ± SD of the luciferase
performed in triplicate. **p% 0.007 relative to hNICD1.
ed steady-state levels. Tubulin was used as a loading control. Intervening lanes
s (injected with 50 pg of indicated mRNA). Data are from at least three clutches
***p < 0.0005 relative to hNICD1.
NA, and donor single-strand oligonucleotides encoding R1758S, S1776C, or
utation in zebrafish Notch1 exhibit defects in somite formation. In contrast, no
f zebrafish Notch1. Graph shows quantification of zebrafish embryos (10–13
trol = 70, S1776C = 165, and R1758S = 189.
creased RFP (K) expression in the Tg[NGN1:GFP] and Tg[Her4:dRFP] lines,
or Tg[NGN1:GFP] transgenics, coronal views are shown at 83 magnification.
S = 28/40, and S1776C = 16/31. For Tg[Her4:dRFP] transgenics, sagittal views
ted = 0/75, control = 0/30, R1758S = 36/57, and S1776C = 49/74. **p < 0.005
ow quantification of zebrafish embryos with reduced GFP (J) or enhanced RFP
embryos and the absence of amino acid changes for all non-affected animals.
NT, neural tube.
(legend on next page)
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suggestions. For cyclohexamide (Sigma-Alderich) chase experiments, media
supplemented with 100 mg/ml cyclohexamide was added to cells at the
0 min time point. Cells were then incubated in the presence of cyclohexamide
for the duration of the experiment.
Transcriptional Activity Assays
HEK293 cells were transiently transfected with 1 mg Hes1-luciferase, 0.5 mg
Renilla luciferase, and 1 mg of the indicated Notch construct. Luciferase and
Renilla activities were assessed after 24 hr using the Dual-Glo Luciferase
Assay System (Promega) in accordance with the manufacturer’s instructions.
Experiments were performed in triplicate and replicated at least two times.
Significance was determined using a two-tailed Student’s t test.
Xenopus Egg Extract Degradation Assays
Detailed methodology for preparing Xenopus egg extract and performing
degradation assays with radiolabeled and luciferase fusion proteins can be
found in Chen et al. (2014). His-CSL-Flag was purified from SF21 cells as pre-
viously described (Vasquez-Del Carpio et al., 2011). Glutathione S-transferase
(GST)-b-catenin (gift from Wenqing Xu) was expressed and purified from bac-
terial cell lysates with glutathione beads (Merck Millipore) in accordance with
the manufacturer’s suggestions.
Immunoblot Analysis
To assess changes in steady-state protein levels, 1 mg of each DNA construct
was transfected into an equivalent number of HEK293 cells. 48 hr post-trans-
fection, cells were lysed by incubation in non-denaturing lysis buffer (50 mM
Tris-HCl [pH 7.4], 300 mM NaCl, 5 mM EDTA, 1% (w/v) Trition X-100, and
1 mM PMSF) for 30 min on ice. Lysates were rigorously vortexed once at
15 min during the incubation. Lysates were cleared by centrifugation. 50 mg
of total protein, assessed using the Bio-Rad protein assay dye reagent
(Bio-Rad), was processed for SDS-PAGE/immunoblotting using standard
techniques. The following antibodies were used: a-Fbxw7 (Bethyl Labora-
tories, Cat# A301-720A), a-MYC (9E10), a-Flag (Sigma-Aldrich), and a-b-tubu-
lin (Clone E7, Developmental Studies Hybridoma Bank, University of Iowa).
Secondary antibodies conjugated to horseradish peroxidase were purchased
from Bethyl Laboratories. Blots were analyzed using ImageJ software.
Statistical Methods
Luciferase fusion degradation experiments were repeated at least twice and
in triplicate. Significance was calculated using a two-tailed Student’s t test
in Excel. Transcriptional assays were performed in triplicate and replicated
at least two times. Significance was determined using a two-tailed Student’s
t test. Autoradiography, immunoblots, and fluoresence microscopy experi-
ments were analyzed using ImageJ software and significance (two-tailed Stu-
dent’s t test) was calculated in Excel. Somite formation assays were assessed
using Fisher’s exact test calculated in Excel.
Additional experimental methods are provided within the Supplemental
Experimental Procedures.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures
and four figures and can be found with this article online at http://dx.doi.org/
10.1016/j.celrep.2016.04.070.Figure 4. N1-Box-Mediated hNICD1 Degradation in Xenopus Egg Extra
(A) Schematic showing overlap of N1-Box (yellow) and RAM domains (blue). Over
(B) CSL inhibits degradation of hNICD1 (but not a CSL binding mutant) in a dose-
Xenopus egg extract with increasing amounts of recombinant CSL. Samples we
(C) Graph shows the mean ± SD of densitometry measurements for two indepen
(D) Steady-state levels of the CSL binding mutant, hNICD111771-74A, are lower t
binding mutants were transfected into HEK293 cells and immunoblotting perform
(E) Graph of densitometry measurements in (D). Graph shows mean ± SD of MYC
***p% 0.001.
(F) Model of N1-Box-mediated regulation of hNotch1 signaling. See text for deta
See also Figure S4.
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